Literature DB >> 2175808

New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.

Y Hamagishi1, S Murata, H Kamei, T Oki, O Adachi, M Ameyama.   

Abstract

Pyrroloquinoline quinone (PQQ) inhibited the chemiluminescence (CL) from mouse peritoneal cells initiated by zymosan, carrageenin and N-formyl-methionyl-leucyl-phenylalanine and CL generated by the xanthine-xanthine oxidase reaction and the lipid peroxidation in the rat brain homogenate. The inhibitory activity of PQQ was more potent than that of idebenone, alpha-tocopherol and ascorbic acid in all the three assay systems. In the xanthine-xanthine oxidase reaction, PQQ had no effect on the formation of uric acid at the concentration of CL inhibition. These results suggest that PQQ might have a radical scavenger-like activity. Structure-activity relationship of PQQ and its six related compounds showed that the 7- and 9-carboxyl groups of PQQ as well as the orthoquinone structure are responsible for the radical scavenger-like activity. In addition, the -NH group in the pyrrole ring of PQQ seemed to be essential for the antilipid peroxidative activity in the rat brain homogenate. When administered i.p., PQQ inhibited the development of 0.1% carrageenin-induced paw edema in rats. These results suggest that PQQ might have therapeutic effects on various diseases, of which development or exacerbation has been known to be associated with radical oxygens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175808

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Production of pyrroloquinoline quinone by using methanol-utilizing bacteria.

Authors:  T Urakami; K Yashima; H Kobayashi; A Yoshida; C Ito-Yoshida
Journal:  Appl Environ Microbiol       Date:  1992-12       Impact factor: 4.792

2.  Pyrroloquinoline quinone protects nucleus pulposus cells from hydrogen peroxide-induced apoptosis by inhibiting the mitochondria-mediated pathway.

Authors:  Lianjun Yang; Zijie Rong; Mingjun Zeng; Yanlin Cao; Xumeng Gong; Lijun Lin; Yong Chen; Wei Cao; Lixin Zhu; Weiren Dong
Journal:  Eur Spine J       Date:  2014-10-28       Impact factor: 3.134

3.  The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury.

Authors:  Lili Zhang; Jie Liu; Chun Cheng; Ying Yuan; Biyun Yu; Aiguo Shen; Meijuan Yan
Journal:  J Neurotrauma       Date:  2011-12-20       Impact factor: 5.269

4.  Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity.

Authors:  Hirokazu Hara; Hideaki Hiramatsu; Tetsuo Adachi
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

5.  Levels of pyrroloquinoline quinone in various foods.

Authors:  T Kumazawa; K Sato; H Seno; A Ishii; O Suzuki
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

6.  Coaxial nanofibers outperform uniaxial nanofibers for the loading and release of pyrroloquinoline quinone (PQQ) for biomedical applications.

Authors:  Sara Ibrahim; Marwan Y Rezk; Mohammed Ismail; Taghrid Abdelrahman; Mona Sharkawy; Ahmed Abdellatif; Nageh K Allam
Journal:  Nanoscale Adv       Date:  2020-06-08

7.  Pyrroloquinoline quinine inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos in mouse bone marrow cells and inhibits wear particle-induced osteolysis in mice.

Authors:  Lingbo Kong; Chongfei Yang; Lifeng Yu; Wanli Smith; Shu Zhu; Jinyu Zhu; Qingsheng Zhu
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

8.  Identification of transcriptional networks responding to pyrroloquinoline quinone dietary supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK pathways.

Authors:  Eskouhie Tchaparian; Lisa Marshal; Gene Cutler; Kathryn Bauerly; Winyoo Chowanadisai; Michael Satre; Calliandra Harris; Robert B Rucker
Journal:  Biochem J       Date:  2010-08-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.